HARRIGAN EDMUND has filed 30 insider transactions across 2 companies since June 2021.
Most recent transaction: a grant/award of 269 shares of INCYTE CORP ($INCY) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 269 | $94.12 | 21,122.0000 | 200,700,000 | 1.29% | 0.00% |
| Dec. 31, 2025 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 245 | $98.77 | 20,853.0000 | 201,429,000 | 1.19% | 0.00% |
| Sept. 30, 2025 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 289 | $84.81 | 20,608.0000 | 210,530,000 | 1.42% | 0.00% |
| June 30, 2025 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 367 | $68.10 | 20,319.0000 | 210,530,000 | 1.84% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 2518 | $0.00 | 19,952.0000 | 210,530,000 | 14.44% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | M | Restricted Stock Units | 9387 | $0.00 | 0.0000 | 166,362,000 | 100.00% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | M | Common Stock | 9387 | $0.00 | 35,041.0000 | 166,362,000 | 36.59% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | A | Restricted Stock Units | 8107 | $0.00 | 8,107.0000 | 166,362,000 | 9999.99% | 0.00% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | A | Director Stock Options (Right to Buy) | 13793 | $0.00 | 13,793.0000 | 166,362,000 | 9999.99% | 0.01% |
| March 31, 2025 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 363 | $60.55 | 17,434.0000 | 210,530,000 | 2.13% | 0.00% |
| Dec. 31, 2024 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 339 | $69.07 | 17,071.0000 | 211,763,000 | 2.03% | 0.00% |
| Sept. 30, 2024 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 378 | $66.10 | 16,732.0000 | 225,928,000 | 2.31% | 0.00% |
| June 28, 2024 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 409 | $60.62 | 16,354.0000 | 225,928,000 | 2.57% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 2830 | $0.00 | 15,945.0000 | 225,928,000 | 21.58% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | M | Restricted Stock Units | 6652 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | A | Restricted Stock Units | 9387 | $0.00 | 9,387.0000 | 163,819,000 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | A | Director Stock Options (Right to Buy) | 15959 | $0.00 | 15,959.0000 | 163,819,000 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Not found | M | Common Stock | 6652 | $0.00 | 25,654.0000 | 163,819,000 | 35.01% | 0.00% |
| March 28, 2024 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 413 | $56.97 | 13,115.0000 | 225,928,000 | 3.25% | 0.00% |
| Dec. 29, 2023 | INCYTE CORP | $INCY | HARRIGAN EDMUND | Director | A | Common Stock | 423 | $62.79 | 12,702.0000 | 223,958,000 | 3.44% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | M | Common Stock | 8552 | $0.00 | 19,002.0000 | 161,683,000 | 81.84% | 0.01% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | M | Restricted Stock Units | 3059 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | M | Restricted Stock Units | 6391 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | M | Restricted Stock Units | 8552 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | A | Director Stock Options (Right to Buy) | 11045 | $0.00 | 11,045.0000 | 161,683,000 | 9999.99% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | A | Restricted Stock Units | 6652 | $0.00 | 6,652.0000 | 161,683,000 | 9999.99% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | M | Common Stock | 6391 | $0.00 | 10,450.0000 | 0 | 157.45% | 0.00% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | HARRIGAN EDMUND | Director | M | Common Stock | 3059 | $0.00 | 4,059.0000 | 0 | 305.90% | 0.00% |